Lucie Tixier Selected Research

Therapeutics

1/2018	Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.
1/2016	Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucie Tixier Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 11/2021 - 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Neoplasms (Cancer) 01/2016
1	Hypertrophy 05/2013
1	Neoplasm Metastasis (Metastasis) 05/2013
1	Massive Hepatic Necrosis 05/2013

Drug/Important Bio-Agent (IBA)

1	Biomarkers (Surrogate Marker)IBA 11/2021
1	micaIBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016
1	Leucovorin (Folinic Acid)FDA Link 01/2016

Therapy/Procedure

2	Precision Medicine 11/2021 - 01/2016
2	Therapeutics 01/2018 - 01/2016
1	Immunotherapy 01/2018
1	Drug Therapy (Chemotherapy) 01/2016
1	Adjuvant Chemotherapy 01/2016
1	Radiotherapy 01/2016
1	Ligation 05/2013